PulseAugur
中
实时 10:48:25
English(EN) Computational De Novo Design of Miniprotein Candidate Neutralizers Targeting the IL-23 Cytokine Subunit p19

设计出可中和IL-23细胞因子新型迷你蛋白

作者 PulseAugur 编辑部 · [1 个来源] ·

研究人员通过计算设计出新型迷你蛋白，旨在中和IL-23细胞因子，后者是IBD和银屑病等炎症性疾病的关键驱动因素。与靶向IL-23受体的现有疗法不同，这些迷你蛋白直接作用于IL-23细胞因子本身，特别是其p19亚基。该研究强调了从头蛋白设计中的挑战，包括评分伪影和稳健的界面预测需求，最终提出了五个有前景的迷你蛋白候选物，它们能结合关键结合位点且与p40亚基无交叉反应。 AI

影响 展示了AI在药物发现和蛋白质工程领域的先进应用。

排序理由 学术论文，详细介绍了新颖的计算蛋白设计方法和结果。[lever_c_demoted from research: ic=1 ai=1.0]

在 arXiv cs.LG 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →

设计出可中和IL-23细胞因子新型迷你蛋白

本文如何被排名

Signal score
11 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
学术论文，详细介绍了新颖的计算蛋白设计方法和结果。[lever_c_demoted from research: ic=1 ai=1.0]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
paper, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
Same-day
Cluster formed today. Ranking reflects the current source set at time of score.

完整方法见我们的编辑标准。

报道来源 [1]

  1. arXiv cs.LG TIER_1 English(EN) · Raghav Paladugu, Fardina Fathmiul Alam ·

    靶向IL-23细胞因子亚基p19的计算从头设计小蛋白候选中和剂

    arXiv:2610.32779v1 Announce Type: cross Abstract: Interleukin-23 (IL-23) drives T-helper-17 inflammation underlying inflammatory bowel disease and psoriasis; anti-p19 antibodies are clinically effective but large, costly, and injectable. De novo miniproteins are an attractive alt…

相关实体

相关话题